NASDAQ:NNOX Shareholder Notice: Lawsuit Alleges Secruities Laws Violations by Nano-X Imaging Ltd.

A lawsuit was filed on behalf of investors in Nano-X Imaging Ltd. (NASDAQ:NNOX) shares over alleged securities laws violations.

Logo

San Diego, CA -- (SBWire) -- 10/18/2021 --An investor, who purchased shares of Nano-X Imaging Ltd. (NASDAQ: NNOX), filed a lawsuit in the over alleged violations of Federal Securities Laws by Nano-X Imaging Ltd.

Investors who purchased shares of Nano-X Imaging Ltd. (NASDAQ: NNOX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 6, 2021. NASDAQ: NNOX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Israel based Nano-X Imaging Ltd. engages in developing and producing X-ray source technology for the medical imaging industry in the United States.

On August 19, 2021, Nano-X Imaging Ltd. revealed that it had "received a request for additional information from the U.S. Food and Drug Administration (the 'FDA') concerning the Company's last 510(k) submission of its multi-source device, Nanox.ARC." The 510(k) submission was placed on hold pending the Company's response.

Shares of Nano-X Imaging Ltd. (NASDAQ: NNOX) declined from $30.71 per share on August 9, 2021, to $21.11 per share on August 20, 2021.

The plaintiff alleges on behalf of purchasers of Nano-X Imaging Ltd. (NASDAQ: NNOX) common shares between June 17, 2021 and August 18, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 17, 2021 and August 18, 2021, the defendants made false and/or misleading statements and/or failed to disclose that Nanox's 510(k) application for the Nanox.ARC (an imaging system that uses a purportedly novel X-ray source) was deficient, thataccordingly, it was unlikely that the U.S. Food and Drug Administration (the "FDA") would approve the 510(k) application for the Nanox.ARC in its current form, that as a result, Nanox had overstated Nanox.ARC's regulatory and commercial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damage

Those who purchased shares of Nano-X Imaging Ltd. (NASDAQ: NNOX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Media Relations Contact

Michael Daniels
Shareholders Foundation
1-858-779-1554
https://www.shareholdersfoundation.com/

View this press release online at: http://rwire.com/1347691